Nekategorizirano

What’s new in ID April 2020 – June 2020. Authors: Marija Kusulja, Vladimir Krajinović   Association of a Care Bundle for Early Sepsis Management With Mortality […]

Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England The United Kingdom introduced a meningococcal group B vaccine (4CMenB, Bexero) into the national immunization […]

The Effect of Infectious Diseases Consultation on Mortality in Hospitalized Patients With MRSA, Candida, and Pseudomonas Bloodstream Infections   Abstract We evaluated the association between infectious […]

Clinical phenotypes in sepsis Clinical phenotypes have been proposed as a potential way to identify those most at risk of dying from sepsis. In a retrospective […]

Lefamulin for the treatment of community-acquired pneumonia Lefamulin is a novel antibiotic with activity against many common community-acquired pneumonia (CAP) pathogens, including Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and […]

  Antibiotic overuse and adverse events in patients with community-acquired pneumonia Several meta-analyses have shown that short-course antibiotic therapy (ie, 5 to 7 days) is as […]

Chronic hepatitis B infections on the rise since 2008 News story 17 Jun 2019   In 2017, the majority (58%) of the almost 27 000 newly […]

IDSA guidelines on asymptomatic bacteriuria (June 2019) The Infectious Diseases Society of America recently released updated guidelines on asymptomatic bacteriuria, which include discussion of populations not […]

The current outbreak in the Democratic Republic of Congo has infected more than 2,000 people, killing at least 1,390 of them.   Uganda announced two more […]